These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2925625)

  • 1. Diethylstilbestrol metabolites and analogs. Stereochemical probes for the estrogen receptor binding site.
    Korach KS; Chae K; Levy LA; Duax WL; Sarver PJ
    J Biol Chem; 1989 Apr; 264(10):5642-7. PubMed ID: 2925625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen receptor stereochemistry: ligand binding orientation and influence on biological activity.
    Chae K; Gibson MK; Korach KS
    Mol Pharmacol; 1991 Nov; 40(5):806-11. PubMed ID: 1944245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple estrogen binding sites in the uterus: stereochemistry of receptor and non-receptor binding of diethylstilbestrol and its metabolites.
    Chae K; Johnston SH; Korach KS
    J Steroid Biochem Mol Biol; 1991 Jan; 38(1):35-42. PubMed ID: 1997122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor stereochemistry: receptor binding and hormonal responses.
    Korach KS; Levy LA; Sarver PJ
    J Steroid Biochem; 1987; 27(1-3):281-90. PubMed ID: 3695485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diethylstilbestrol metabolites and analogs: differential ligand effects on estrogen receptor interactions with nuclear matrix sites.
    Metzger DA; Curtis S; Korach KS
    Endocrinology; 1991 Apr; 128(4):1785-91. PubMed ID: 2004602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor stereochemistry: ligand binding and hormonal responsiveness.
    Korach KS; Chae K; Gibson M; Curtis S
    Steroids; 1991 May; 56(5):263-70. PubMed ID: 1877066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diethylstilbestrol metabolites and analogs. Biochemical probes for differential stimulation of uterine estrogen responses.
    Korach KS; Fox-Davies C; Quarmby VE; Swaisgood MH
    J Biol Chem; 1985 Dec; 260(29):15420-6. PubMed ID: 4066677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of the estrogen receptor ligand-binding domain: influence of ligand structure and stereochemistry on transactivation.
    Kohno H; Bocchinfuso WP; Gandini O; Curtis SW; Korach KS
    J Mol Endocrinol; 1996 Jun; 16(3):277-85. PubMed ID: 8782086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoter and species specific differential estrogen-mediated gene transcription in the uterus and cultured cells using structurally altered agonists.
    Curtis SW; Shi H; Teng C; Korach KS
    J Mol Endocrinol; 1997 Jun; 18(3):203-11. PubMed ID: 9195474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity.
    Duax WL; Swenson DC; Strong PD; Korach KS; McLachlan J; Metzler M
    Mol Pharmacol; 1984 Nov; 26(3):520-5. PubMed ID: 6548545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of (+)-, (-)- and (+/-)-indenestrols A and B on microtubule polymerization.
    Oda T; Sakakibara Y; Sato Y; Hanzawa H; Hata T
    Chem Pharm Bull (Tokyo); 1992 Mar; 40(3):588-92. PubMed ID: 1611675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diethylstilbestrol metabolites and analogs. New probes for the study of hormone action.
    Korach KS; Metzler M; McLachlan JA
    J Biol Chem; 1979 Sep; 254(18):8963-8. PubMed ID: 479173
    [No Abstract]   [Full Text] [Related]  

  • 13. The testicular estrogen receptor system in two strains of mice differing in susceptibility to estrogen-induced Leydig cell tumors.
    Sato B; Spomer W; Huseby RA; Samuels LT
    Endocrinology; 1979 Mar; 104(3):822-31. PubMed ID: 436739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
    Attardi B; Happe HK
    Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen dependent induction of low affinity binding sites in the nuclear fraction of rat uterus.
    De Hertogh R; Ekka E; Vanderheyden I
    J Steroid Biochem; 1986 Jun; 24(6):1171-7. PubMed ID: 3736044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor residues required for stereospecific ligand recognition and activation.
    Bocchinfuso WP; Korach KS
    Mol Endocrinol; 1997 May; 11(5):587-94. PubMed ID: 9139802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences between estrogen- and antiestrogen-estrogen receptor complexes from human breast tumors identified with an antibody raised against the estrogen receptor.
    Tate AC; Greene GL; DeSombre ER; Jensen EV; Jordan VC
    Cancer Res; 1984 Mar; 44(3):1012-8. PubMed ID: 6692388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogenic activity in vivo and in vitro of some diethylstilbestrol metabolites and analogs.
    Korach KS; Metzler M; McLachlan JA
    Proc Natl Acad Sci U S A; 1978 Jan; 75(1):468-71. PubMed ID: 272664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relative binding affinity of diethylstilbestrol to uterine nuclear estrogen receptor: effect of serum and serum albumin.
    Okulicz WC; Johnson LD
    Proc Soc Exp Biol Med; 1987 Sep; 185(4):478-83. PubMed ID: 3615411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different nuclear binding sites for antiestrogen and estrogen receptor complexes.
    Ruh TS; Baudendistel LJ
    Endocrinology; 1977 Feb; 100(2):420-6. PubMed ID: 832632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.